INSM - Insmed Incorporated

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development109,749122,72174,277
Selling General and Administrative79,17150,67943,216
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-188,920-173,400-117,493
Income from Continuing Operations
Total Other Income/Expenses Net1,924723228
Earnings Before Interest and Taxes-186,996-172,677-117,265
Interest Expense5,9253,4982,889
Income Before Tax-192,921-176,175-120,154
Income Tax Expense-27298-1,971
Minority Interest---
Net Income From Continuing Ops-192,649-176,273-118,183
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-192,649-176,273-118,183
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-192,649-176,273-118,183